The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Oxaliplatin desensitization in patients with GI malignancies: Experience from a tertiary cancer center.
 
Jacqueline Connell
No Relationships to Disclose
 
Panagiotis J. Vlachostergios
No Relationships to Disclose
 
Joseph Thomas David Williams
No Relationships to Disclose
 
Jurgees Hassan
No Relationships to Disclose
 
Wasat Mansoor
Honoraria - BMS; BMS; Servier
Consulting or Advisory Role - BMS; SERVIER
Speakers' Bureau - Lilly
Travel, Accommodations, Expenses - Ipsen; SERVIER; SERVIER
 
Saifee Mullamitha
No Relationships to Disclose
 
Richard Hubner
No Relationships to Disclose
 
Michael Braun
Honoraria - Amgen; Boehringer Ingelheim; Pierre Fabre; SERVIER
Travel, Accommodations, Expenses - SERVIER
 
Mark Saunders
No Relationships to Disclose
 
Jorge Barriuso
Consulting or Advisory Role - Ellipses Pharma; Nutricia
Speakers' Bureau - ipsen; Novartis; Pfizer
Research Funding - Pfizer; Pfizer
Travel, Accommodations, Expenses - Advanced Accelerator Applications; Ipsen; NanoString Technologies; Novartis; Pfizer; Rand Italy
 
Tom Waddell
Stock and Other Ownership Interests - The Christie Clinic LLP
Honoraria - Bristol-Myers Squibb; EUSA Pharma; Ipsen; Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai Europe; Ipsen; Merck Sharp & Dohme; Pfizer; Roche
Research Funding - Bristol-Myers Squibb (Inst); Eisai (Inst); Ipsen (Inst); Merck Sharp & Dohme (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; EUSA Pharma; Ipsen
 
Nooreen Alam
No Relationships to Disclose
 
Konstantinos Kamposioras
No Relationships to Disclose